" class="no-js "lang="en-US"> Kleiner Device Labs Completes First Surgery With KG2 Surge Flow-Thru Interbody System - Medtech Alert
Tuesday, April 23, 2024

Kleiner Device Labs Completes First Surgery With KG2 Surge Flow-Thru Interbody System

Kleiner Device Labs today announced that its new KG™2 Surge™ flow-thru interbody system was used in its first surgical procedure. Dr. Anders Cohen performed a single-level TLIF, fusing L5-S1 at The Brooklyn Hospital Center on July 19, 2022. Utilizing the new device, bone graft delivered through the KG 2 conduit was more than three times the volume of the void of the collapsed disk space.

Noted Dr. Cohen post-surgery, “I was honored to perform the inaugural KG 2 Surge spinal fusion procedure. The system worked flawlessly, allowing precision placement of the interbody cage and fusion graft in a seamless sequential manner. The integrated fusion delivery system enabled a quick, maximum delivery of the graft material to the re-expanded disc space. The system is intuitive and reduces the number of steps usually needed to perform this procedure. There is minimal learning curve for the physician and our team.”


The KG2 Surge flow-thru interbody system is a single-patient-use bone graft delivery tool coupled with a 3D-printed titanium I-Beam fusion implant. The implant has no lateral walls and serves as a conduit for unimpeded flow of a broad spectrum of bone graft materials through the pre-attached, rectangular insertion tool. The rectangular cannula maximizes the cross-sectional area available for graft material flow and eliminates the challenge of trying to apply bone graft after cage insertion. Since the system comes pre-assembled and sterilized in a single use tray, there is minimal scrub tech training and no implant tray re-processing/sterilization — an ideal system for an ASC or hospital. Also, the implant is directly inserted—it is not touched or pre-packed. The KG2 system allows for a single insertion process to take the place of the multi-step, multi-instrument pass practice that is typical of current spinal fusion procedures. The surgical procedure with KG2 Surge spares contusion of delicate nerve tissue and reduces the risk of surgical site infection. Because the system comes pre-sterilized and pre-assembled, it also eliminates the back table “fiddle factor.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more